热门资讯> 正文
CooperCompanies因指引调整触及52周低点
2026-09-11 02:26
- CooperCompanies (COO) hit a 52-week low of $51.08 earlier on Thursday, a drop of nearly 20% from Wednesday's close, as the vision care company continued to reel from a downward change in full-year revenue and EPS guidance.
- Both fiscal 2026 guidance ranges are now below consensus figures.
- CooperCompanies also decided after a strategic review to not sell its women's health-centered CooperSurgical division. BNP Paribas analyst Navann Ty said that could have also contributed to the share decline.
- She added that CooperSurgical's flat organic growth in FY26 Q3 was "another setback relative to competitors’ operating performance."
- Cooper shares are down ~14% in Thursday afternoon trading.
More on CooperCompanies
- The Cooper Companies, Inc. (COO) Q3 2026 Earnings Call Transcript
- Cooper Companies: Cash Conversion And Strategic Optionality Create A Re-Rating Setup
- Cooper outlines Q4 2026 EPS of $1.05-$1.09 while completing strategic review and adding $1B to buyback authorization
- CooperCompanies keeping CooperSurgical; shares drop on updated guidance
- Seeking Alpha’s Quant Rating on The Cooper Companies
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。